These results provide strong evidence that BRCA1 and CHK1, and to a lesser extent RAD51, are critical mediators of the cooperative antileukemic activities of combined panobinostat and cytarabine or DNR in AML cells. The gene discussed is RAD51; the disease is acute myeloid leukemia.